Assessment of miRNA 106a-5p and 375-3p Expression in the Context of the Wnt/β-Catenin Pathway—Comparison of Prostate Adenocarcinoma and Benign Prostatic Hyperplasia Tissues
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262412073 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Magdalena Smereczańska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Cytophysiology, Medical University of Bialystok, Mickiewicza 2C Street, 15-222 Bialystok, Poland. Hauptthemen laut MEDLINE: MicroRNAs, Prostatic Hyperplasia, Prostatic Neoplasms, Wnt Signaling Pathway. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uniwersytet Medyczny w Białymstoku.
Abstract (Originalsprache)
Prostate adenocarcinoma is mainly diagnosed based on serum PSA levels, but elevated PSA levels can also be caused by BPH, which weakens its specificity. Recent scientific studies have demonstrated that specific microRNAs regulate cancer cell proliferation by modulating the Wnt/β-catenin pathway. To date, no published literature has provided a comprehensive assessment of the interactions between miR-106a-5p and miR-375-3p and components of the Wnt/β-catenin pathway in prostate cancer. Therefore, the aim of the present study was to perform a pilot evaluation of the expression of miRNAs 106a-5p and 375-3p, as well as β-catenin, Fzd8, Wnt5a, and cyclin D1 in prostate adenocarcinoma compared with BPH. The study material consisted of samples collected from 30 patients with prostate cancer and 30 with BPH. Protein expression was analyzed using IHC and qRT-PCR methods, while miRNA levels were quantified by dPCR. Our study results revealed lower immunoreactivity and expression of genes encoding β-catenin, Fzd8, Wnt5a, and cyclin D1 and significantly higher fluorescence intensity of miRNA 106a-5p and 375-3p with prostate adenocarcinoma compared to BPH. These parallel alterations in miRNA expression and Wnt/β-catenin-related components reflect disease-specific expression patterns and warrant further investigation in larger cohorts to determine their potential utility as diagnostic biomarkers in prostate diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Cytophysiology, Medical University of Bialystok, Mickiewicza 2C Street, 15-222 Bialystok, Poland.
- Department of Urology, Medical University of Bialystok, M. Skłodowskiej-Curie 24A Street, 15-276 Bialystok, Poland.
ORCID-Profile: Magdalena Smereczańska, Grzegorz Młynarczyk
Förderung
- Uniwersytet Medyczny w Białymstoku
Zitieren
APA
Smereczańska, M., Domian, N., Młynarczyk, G., & Kasacka, I. (2025). Assessment of miRNA 106a-5p and 375-3p Expression in the Context of the Wnt/β-Catenin Pathway—Comparison of Prostate Adenocarcinoma and Benign Prostatic Hyperplasia Tissues. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262412073
Vancouver
Smereczańska M, Domian N, Młynarczyk G, Kasacka I. Assessment of miRNA 106a-5p and 375-3p Expression in the Context of the Wnt/β-Catenin Pathway—Comparison of Prostate Adenocarcinoma and Benign Prostatic Hyperplasia Tissues. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262412073
BibTeX
@article{Smereczaska2025,
author = {Smereczańska, Magdalena and Domian, Natalia and Młynarczyk, Grzegorz and Kasacka, Irena},
title = {Assessment of miRNA 106a-5p and 375-3p Expression in the Context of the Wnt/β-Catenin Pathway—Comparison of Prostate Adenocarcinoma and Benign Prostatic Hyperplasia Tissues},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262412073}
}
EUVIMED